Clinical Trial: Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Double-Blind, Placebo-Controlled, Multi-Center, Randomized Trial of the Safety and Efficacy of Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Same as current

Current Secondary Outcome: To evaluate the efficacy of metyrosine (Demser®) for the treatment of psychosis in patients with VCFS [ Time Frame: 13 weeks ]

Original Secondary Outcome: Same as current

Information By: Valeant Pharmaceuticals International, Inc.

Dates:
Date Received: May 19, 2010
Date Started: June 2010
Date Completion: September 2011
Last Updated: September 28, 2011
Last Verified: September 2011